| Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development J Wu, H Matthaei, A Maitra, M Dal Molin, LD Wood, JR Eshleman, ... Science translational medicine 3 (92), 92ra66-92ra66, 2011 | 826 | 2011 |
| International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer MI Canto, F Harinck, RH Hruban, GJ Offerhaus, JW Poley, I Kamel, Y Nio, ... Gut 62 (3), 339-347, 2013 | 799 | 2013 |
| Frequent detection of pancreatic lesions in asymptomatic high-risk individuals MI Canto, RH Hruban, EK Fishman, IR Kamel, R Schulick, Z Zhang, ... Gastroenterology 142 (4), 796-804, 2012 | 679 | 2012 |
| Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways J Wu, Y Jiao, M Dal Molin, A Maitra, RF De Wilde, LD Wood, JR Eshleman, ... Proceedings of the National Academy of Sciences 108 (52), 21188-21193, 2011 | 633 | 2011 |
| EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification MF Catalano, A Sahai, M Levy, J Romagnuolo, M Wiersema, W Brugge, ... Gastrointestinal endoscopy 69 (7), 1251-1261, 2009 | 618 | 2009 |
| Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study MI Canto, M Goggins, RH Hruban, GM Petersen, FM Giardiello, C Yeo, ... Clinical gastroenterology and hepatology 4 (6), 766-781, 2006 | 600 | 2006 |
| Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial BF Overholt, CJ Lightdale, KK Wang, MI Canto, S Burdick, RC Haggitt, ... Gastrointestinal endoscopy 62 (4), 488-498, 2005 | 563 | 2005 |
| Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach MI Canto, M Goggins, CJ Yeo, C Griffin, JE Axilbund, K Brune, SZ Ali, ... Clinical Gastroenterology and Hepatology 2 (7), 606-621, 2004 | 509 | 2004 |
| Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology C Rosty, L Christa, S Kuzdzal, WM Baldwin, ML Zahurak, F Carnot, ... Cancer research 62 (6), 1868-1875, 2002 | 503 | 2002 |
| Endosonographic differentiation of benign and malignant stromal cell tumors A Chak, MI Canto, T Rösch, HJ Dittler, RH Hawes, TL Tio, CJ Lightdale, ... Gastrointestinal endoscopy 45 (6), 468-473, 1997 | 445 | 1997 |
| A combination of molecular markers and clinical features improve the classification of pancreatic cysts S Springer, Y Wang, M Dal Molin, DL Masica, Y Jiao, I Kinde, A Blackford, ... Gastroenterology 149 (6), 1501-1510, 2015 | 411 | 2015 |
| Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry J Koopmann, Z Zhang, N White, J Rosenzweig, N Fedarko, S Jagannath, ... Clinical Cancer Research 10 (3), 860-868, 2004 | 407 | 2004 |
| Pancreatic cancer TP Yeo, RH Hruban, SD Leach, RE Wilentz, TA Sohn, SE Kern, ... Current problems in cancer 26 (4), 176-275, 2002 | 407 | 2002 |
| Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus MIF Canto, S Setrakian, RE Petras, E Blades, A Chak, MV Sivak Jr Gastrointestinal endoscopy 44 (1), 1-7, 1996 | 387 | 1996 |
| Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium M Goggins, KA Overbeek, R Brand, S Syngal, M Del Chiaro, DK Bartsch, ... Gut 69 (1), 7-17, 2020 | 385 | 2020 |
| Methylene blue–directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus MIF Canto, S Setrakian, J Willis, A Chak, R Petras, NR Powe, MV Sivak Jr Gastrointestinal endoscopy 51 (5), 560-568, 2000 | 384 | 2000 |
| Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer K Brune, T Abe, M Canto, L O’Malley, AP Klein, A Maitra, NV Adsay, ... The American journal of surgical pathology 30 (9), 1067, 2006 | 368 | 2006 |
| Advances in counselling and surveillance of patients at risk for pancreatic cancer RE Brand, MM Lerch, WS Rubinstein, JP Neoptolemos, DC Whitcomb, ... Gut 56 (10), 1460-1469, 2007 | 340 | 2007 |
| MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls A Li, J Yu, H Kim, CL Wolfgang, MI Canto, RH Hruban, M Goggins Clinical cancer research 19 (13), 3600-3610, 2013 | 335 | 2013 |
| A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? JK Law, A Ahmed, VK Singh, VS Akshintala, MT Olson, SP Raman, SZ Ali, ... Pancreas 43 (3), 331, 2014 | 334 | 2014 |
